'Masked' cancer drug stealthily trains immune system to kill tumors while sparing healthy tissues

by Aslan Mansurov,The ConversationDendritic cells (green) produce cytokines like IL-12, which can train T cells (pink) to attack tumors. Credit:Victor Segura Ibarra and Rita Serda/National

Updated on: March 30,2024

'Masked' cancer drug stealthily trains immune system to kill tumors while sparing healthy tissues

by Aslan Mansurov,The ConversationDendritic cells (green) produce cytokines like IL-12, which can train T cells (pink) to attack tumors. Credit:Victor Segura Ibarra and Rita Serda/National

Updated on:March 30,2024

Genes reveal kidney cancer's risk of recurrence

byMcGill UniversityDisease-Free Survival outcomes amongst genomic groups when applied to the 247 VHL mutated ccRCCs from the TCGA dataset. Credit:Clinical Cancer Research(2023). DOI:

Updated on: December 25,2023

Genes reveal kidney cancer's risk of recurrence

byMcGill UniversityDisease-Free Survival outcomes amongst genomic groups when applied to the 247 VHL mutated ccRCCs from the TCGA dataset. Credit:Clinical Cancer Research(2023). DOI:

Updated on:December 25,2023

Nuclear radiologists 'outsmart' prostate cancer with an apparently ineffective drug

bySaarland UniversityProfessor Dr. Samer Ezziddin from Saarland University/Saarland University Hospital. Credit: Saarland University/Thorsten MohrWhen a non-scientist tries to imagine a scientis

Updated on: December 22,2023

Nuclear radiologists 'outsmart' prostate cancer with an apparently ineffective drug

bySaarland UniversityProfessor Dr. Samer Ezziddin from Saarland University/Saarland University Hospital. Credit: Saarland University/Thorsten MohrWhen a non-scientist tries to imagine a scientis

Updated on:December 22,2023

Melanoma misconception: Dark skin tones at risk, too

by Sonya GoinsCredit: Unsplash/CC0 Public DomainThe myth that people with dark skin are immune to melanoma, a type of skin cancer, has persisted for many years. It's a dangerous misconception that

Updated on: January 10,2024

Melanoma misconception: Dark skin tones at risk, too

by Sonya GoinsCredit: Unsplash/CC0 Public DomainThe myth that people with dark skin are immune to melanoma, a type of skin cancer, has persisted for many years. It's a dangerous misconception that

Updated on:January 10,2024

Top medical groups, hospitals urge better access to lung cancer screening

by Cara MurezScreening tests routinely catch cases of breast and colon cancer early, but a screening test for lung cancer is sorely underused in high-risk people and that needs to change, more than 50

Updated on: December 20,2023

Top medical groups, hospitals urge better access to lung cancer screening

by Cara MurezScreening tests routinely catch cases of breast and colon cancer early, but a screening test for lung cancer is sorely underused in high-risk people and that needs to change, more than 50

Updated on:December 20,2023

Discovery of drug candidate to potentially tackle ER-positive breast cancer

byMonash UniversityCredit:Cell Chemical Biology(2023). DOI: 10.1016/j.chembiol.2023.07.005An international team of researchers, led by Pfizer in collaboration with Monash University

Updated on: December 30,2023

Discovery of drug candidate to potentially tackle ER-positive breast cancer

byMonash UniversityCredit:Cell Chemical Biology(2023). DOI: 10.1016/j.chembiol.2023.07.005An international team of researchers, led by Pfizer in collaboration with Monash University

Updated on:December 30,2023

Recent screening rose among people under 50 after release of new colorectal guidelines

byAmerican Cancer SocietyCredit: CC0 Public DomainRecent colorectal cancer screening rates more than doubled among people ages 45 to 49 in the months after the release of updated American Cancer

Updated on: December 22,2023

Recent screening rose among people under 50 after release of new colorectal guidelines

byAmerican Cancer SocietyCredit: CC0 Public DomainRecent colorectal cancer screening rates more than doubled among people ages 45 to 49 in the months after the release of updated American Cancer

Updated on:December 22,2023

Cancer test shows promise for bringing the benefits of immunotherapy to more patients

byBrigham and Women’s HospitalCredit: Pixabay/CC0 Public DomainImmunotherapy is a highly effective treatment for patients whose cancers harbor mismatch repair deficiency, and a new study identif

Updated on: January 25,2024

Cancer test shows promise for bringing the benefits of immunotherapy to more patients

byBrigham and Women’s HospitalCredit: Pixabay/CC0 Public DomainImmunotherapy is a highly effective treatment for patients whose cancers harbor mismatch repair deficiency, and a new study identif

Updated on:January 25,2024

Could artificial sweeteners alter your microbiome?

by Dennis ThompsonYou may think that artificial sweeteners can help you lose some weight, but a new study finds they are no good for your gut's microbiome.People who useaspartame(Equal

Updated on: May 06,2024

Could artificial sweeteners alter your microbiome?

by Dennis ThompsonYou may think that artificial sweeteners can help you lose some weight, but a new study finds they are no good for your gut's microbiome.People who useaspartame(Equal

Updated on:May 06,2024

New research finds oral leukemia therapy to work as well as intravenous decitabine

by Hackensack Meridian HealthCredit: Pixabay/CC0 Public DomainResearchers at Hackensack Meridian's John Theurer Cancer Center (JTCC), are part of a published Phase 3 study reporting on the equival

Updated on: March 21,2024

New research finds oral leukemia therapy to work as well as intravenous decitabine

by Hackensack Meridian HealthCredit: Pixabay/CC0 Public DomainResearchers at Hackensack Meridian's John Theurer Cancer Center (JTCC), are part of a published Phase 3 study reporting on the equival

Updated on:March 21,2024

Combination immunotherapy produces high response rate in early results of trial targeting high-risk follicular lymphoma

byUniversity of Miami Leonard M. Miller School of MedicineCancer cell during cell division. Credit: National Institutes of HealthResearchers conducting a Phase 2 clinical trial at Sylvester Comp

Updated on: January 26,2024

Combination immunotherapy produces high response rate in early results of trial targeting high-risk follicular lymphoma

byUniversity of Miami Leonard M. Miller School of MedicineCancer cell during cell division. Credit: National Institutes of HealthResearchers conducting a Phase 2 clinical trial at Sylvester Comp

Updated on:January 26,2024

Looking at the environment around tumors could help predict how cancer spreads

byUniversity College LondonRepresentative images of high granulocyte infiltration in the tumor nest and stroma for LUAD (left) and LUSC (right). Credit:Cancer Discovery(2024). DOI: 1

Updated on: April 28,2024

Looking at the environment around tumors could help predict how cancer spreads

byUniversity College LondonRepresentative images of high granulocyte infiltration in the tumor nest and stroma for LUAD (left) and LUSC (right). Credit:Cancer Discovery(2024). DOI: 1

Updated on:April 28,2024